Codon Capital

Codon Capital is a venture capital firm based in San Francisco, California, focusing on early-stage investments in life sciences companies. The firm specializes in two key areas: Therapeutics and Synthetic Biology, aiming to translate innovative research into viable products and startups. Their investment strategy emphasizes the potential of these sectors to revolutionize healthcare and agriculture.

The firm's portfolio includes companies such as Pivot Bio, Good Therapeutics, Ansa Biotechnologies, Seismic Therapeutic, EpiBiologics, Bonum Therapeutics, and AIRNA. Codon Capital's approach combines financial support with strategic guidance to foster the growth of these startups. The firm has a history of participating in various funding rounds, including Series A and Series B investments.

Codon Capital's investment philosophy centers on identifying and nurturing groundbreaking innovations in the life sciences sector. By focusing on early-stage companies, the firm seeks to drive advancements that address critical challenges in healthcare and agriculture, contributing to the development of transformative solutions in these industries.